Search This Blog

Tuesday, February 26, 2019

Theravance Biopharma reports Q4 EPS (92c), consensus ($1.06)

Reports Q4 revenue $15.7M, consensus $23.43M.
https://thefly.com/landingPageNews.php?id=2870653
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)